TG Therapeutics (NASDAQ:TGTX) Rating Increased to Hold at StockNews.com
TG Therapeutics (NASDAQ:TGTX – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. A number of other equities analysts have also issued reports on the company. HC Wainwright raised their price target on TG Therapeutics from $49.00 to $55.00 and gave the stock […]
More Stories
A New Dawn: Life in America Without the Federal Reserve and With Trump’s Policies Fully Enacted
By Stephen Zogopoulos, USNN World News The Great Reset — But For the People What if the true “Great Reset”...
Wall Street Is Not Your Friend: How Global Elites Are Sabotaging President Trump’s Mission to Restore the American Middle Class
By Stephen Zogopoulos, USNN World News Wall Street is not your friend.Behind the skyscrapers of lower Manhattan, beneath the buzzwords...
Invesco Ltd. Sells 144,946 Shares of Darling Ingredients Inc. (NYSE:DAR)
Invesco Ltd. reduced its holdings in Darling Ingredients Inc. (NYSE:DAR – Free Report) by 19.6% in the fourth quarter, according...
iomart Group (LON:IOM) Stock Price Down 16.1% – Should You Sell?
iomart Group plc (LON:IOM – Get Free Report) shares were down 16.1% on Friday . The company traded as low...
iomart Group (LON:IOM) Trading Down 16.1% – Here’s What Happened
Shares of iomart Group plc (LON:IOM – Get Free Report) fell 16.1% on Friday . The company traded as low...
Sienna Resources (CVE:SIE) Trading Down 14.3% – Here’s What Happened
Sienna Resources Inc. (CVE:SIE – Get Free Report) traded down 14.3% during mid-day trading on Friday . The company traded...